Earlier this year, ZimVie selected Brainlab to help achieve its goal of building out a comprehensive spinal surgery system through a partnership—rather than starting from scratch—and, so far, the company appears to have chosen correctly.

今年早些时候，ZimVie选择Brainlab帮助实现通过合作伙伴关系建立全面脊柱手术系统的目标，而不是从头开始，到目前为止，该公司似乎已经正确选择。

Case in point: ZimVie announced Thursday that it’s expanding the terms of its collaboration with Brainlab. Now, in addition to integrating its own spinal fixation devices with Brainlab’s surgical imaging, planning and navigation tools to make them compatible for use by surgeons around the world, ZimVie has signed on to co-market Brainlab’s technology alongside its own devices..

举例来说：ZimVie周四宣布正在扩大与Brainlab的合作条款。现在，除了将自己的脊柱固定装置与Brainlab的手术成像，计划和导航工具相结合，使其与世界各地的外科医生兼容外，ZimVie还与自己的装置一起共同销售Brainlab的技术。。

“We will benefit from a complementary customer base with little overlap in existing accounts,” Rebecca Whitney, president of ZimVie’s global spine business, said in the announcement. “The introduction of the Brainlab portfolio of enabling technologies to ZimVie surgeon customers represents potential upside for both companies and helps us to make an impact on the lives of physicians and patients.”.

ZimVie全球脊柱业务总裁Rebecca Whitney在公告中说：“我们将从现有账户几乎没有重叠的互补客户群中受益。“向ZimVie外科医生客户推出Brainlab启用技术组合代表了两家公司的潜在优势，并帮助我们对医生和患者的生活产生影响。”。

The addition of the co-marketing agreement feeds into ZimVie’s recent focus on “expanding our portfolio with enabling technology to drive greater adoption across our spine portfolio,” CEO Vafa Jamali added in the release.

共同营销协议的加入促成了ZimVie最近关注的“扩大我们的投资组合，使我们的脊柱投资组合得到更多采用”，首席执行官Vafa Jamali在该版本中添加。

ZimVie first announced the collaboration with Brainlab in its fourth-quarter earnings report in March. It brought the two companies together to adapt the former’s Vital and Virage minimally invasive spinal fixation systems with the latter’s spine-specific products. That includes Brainlab’s software offerings, which use artificial intelligence, mixed reality and other high-tech tools to build digital models of each patient’s anatomy that can help guide surgeons through an entire procedure as well as hardware including robotic assistants and imaging machines..

ZimVie在3月份的第四季度收入报告中首次宣布与Brainlab的合作。它将两家公司聚集在一起，使前者的重要和病毒微创脊柱固定系统与后者的脊柱专用产品相适应。其中包括Brainlab的软件产品，这些产品使用人工智能，混合现实和其他高科技工具来构建每个患者解剖结构的数字模型，可以帮助指导外科医生完成整个过程以及硬件，包括机器人助手和成像机。。

During a call with investors alongside the release of that full-year earnings report, Jamali said their collaborative work had already begun.

在发布全年收益报告的同时与投资者打电话时，Jamali表示他们的合作工作已经开始。

The CEO described how the partnership would fulfill a plan dating back to ZimVie’s earliest days, when it spun out from Zimmer Biomet as a standalone spine- and dentistry-focused business in the spring of 2022.

首席执行官描述了这种合作关系将如何实现一个可以追溯到ZimVie最早的日子的计划，当时它在2022年春天从Zimmer Biomet创立了独立的脊柱和牙科业务。

“At the time of the spin, I announced that we would partner, rather than build, an enabling technology offering with an established leader in the space, and Brainlab fits exactly with our strategy to leverage broadly compatible solutions with an established footprint to drive greater pull-through across our spine portfolio,” he said..

“在spin之时，我宣布我们将合作而不是建立一项在空间中具有成熟领导者的有利技术，Brainlab完全符合我们的战略，即利用具有既定足迹的广泛兼容解决方案来推动更大的发展穿过我们的脊柱组合，”他说。。

The Brainlab partnership will also check off another box for ZimVie: boosting its spine portfolio, where net sales fell nearly 17% year over year during its first year as a standalone company.

Brainlab partnership还将检查ZimVie的另一个盒子：提升其脊柱组合，在独立公司的第一年，净销售额逐年下降近17%。

ZimVie “had some gaps” in the spine portfolio, Jamali said on the call, as well as “some commercial activities that we uncovered through the year that were frankly suboptimal.”

Jamali在电话中说，ZimVie在脊柱产品组合中“存在一些差距”，以及“我们全年发现的一些商业活动坦率地说是次优的”

“We need to really perform and manage some of our commercial operations. With all that volatility inside spine, we focused on the portfolio,” he continued. “So, we added an opportunity to do an R&D program with Brainlab. That’s going to fill a gap for us with respect to enabling technology. It’s a gap that we had coming out of Zimmer Biomet that I think we’ve effectively filled, and we’ll start to work toward that.”.

他继续说：“我们需要真正执行和管理我们的一些商业运营。鉴于脊柱内部的所有波动，我们将重点放在投资组合上。”。“因此，我们增加了一个与Brainlab合作开展研发计划的机会，这将填补我们在使能技术方面的空白。我认为我们已经有效填补了Zimmer Biomet的空白，我们将开始为此努力。”。